SCHEMBL5871749

SCHEMBL5871749

O=S(=O)(C(Cl)(Cl)c1ccccc1)C(Cl)(Cl)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
CYP1A2 P05177 1/20 0.46
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA5A P35218 2/20 0.43
CA9 Q16790 2/20 0.43
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KCNN4 O15554 2/20 0.38
HTR6 P50406 1/20 0.38
NR3C2 P08235 3/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA7 P43166 1/20 0.35
PLA2G7 Q13093 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8775959 0.80 CYP1A2 (0.48) TSHRCYP1A2CA1CA2CA5A
SCHEMBL11838595 0.78 ALDH1A1 (0.46) TSHRCYP1A2CA1CA2CA5A
Chlorotriphenylmethane SCHEMBL16781670 0.74 TSHR (0.65) TSHRCYP1A2ALDH1A1KCNN4PTPN1
Chlorotriphenylmethane SCHEMBL461 0.74 TSHR (0.65) TSHRCYP1A2ALDH1A1KCNN4PTPN1
SCHEMBL8138277 0.72 CA1 (0.46) TSHRCYP1A2CA1CA2CA5A
Chlorotriphenylmethane SCHEMBL113884 0.71 TSHR (0.61) TSHRCYP1A2ALDH1A1KCNN4PTPN1
Chlorotriphenylmethane SCHEMBL7246540 0.71 TSHR (0.61) TSHRCYP1A2ALDH1A1KCNN4PTPN1
Chlorotriphenylmethane SCHEMBL29446246 0.71 TSHR (0.61) TSHRCYP1A2ALDH1A1KCNN4PTPN1
Chlorotriphenylmethane SCHEMBL7567317 0.71 TSHR (0.61) TSHRCYP1A2ALDH1A1KCNN4PTPN1
Chlorotriphenylmethane SCHEMBL11237663 0.71 TSHR (0.61) TSHRCYP1A2ALDH1A1KCNN4PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552199-A1 IMPROVED STABLE AQUEOUS FORMULATION OF (E)-4-CARBOXYSTYRYL-4-CHLOROBENZYL SULFONE Onconova Therapeutics, Inc. (US) 2013-02-06 EP disclosed
US-7056953-B2 (E)-styryl sulfone anticancer agents TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-06-06 US disclosed
US-6762207-B1 TARGETING RECEPTOR TYROSINE KINASES; SELECTIVE TUMOR CELL APOPTOSIS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2004-07-13 US disclosed
US-6667346-B2 Administration of a radioprotective alpha, beta unsaturated aryl sulfone compound to a patient prior to anticancer radiotherapy reduces cytotoxic side effects of radiation on normal cells TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2003-12-23 US disclosed
US-6656973-B2 Anticancer chemotherapy, and cytoprotective agents administered before, during or after chemotherapy to protect the normal cells of the patient TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2003-12-02 US disclosed